Este ejemplo es muy grafico ya que demuestra como cualquier persona con acceso a internet puede publicar información que sin querer o con intención puede lograr tener un impacto global.

• for: social tipping point, STP
• title
  • Creating Change: How to Make Big Things Happen
• guest
  • Damon Centola
• description
  • a very clear exposition of how complex contagion works and what must be done to spread complex behavior change
• comment
  • this is particularly important for rapid whole system change and mobilizing a bottom-up movement to deal with our current polycrisis

!- importance of viral spread of new ideas : on debt - if enough people think differently about it - it will also change the social design of debt within society

Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2021). Universal Coronavirus Vaccines—An Urgent Need. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMp2118468

Regev-Yochay, G., Gonen, T., Gilboa, M., Mandelboim, M., Indenbaum, V., Amit, S., Meltzer, L., Asraf, K., Cohen, C., Fluss, R., Biber, A., Nemet, I., Kliker, L., Joseph, G., Doolman, R., Mendelson, E., Freedman, L. S., Harats, D., Kreiss, Y., & Lustig, Y. (2022). 4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC (p. 2022.02.15.22270948). medRxiv. https://doi.org/10.1101/2022.02.15.22270948

Lipsitch, M., Krammer, F., Regev-Yochay, G., Lustig, Y., & Balicer, R. D. (2021). SARS-CoV-2 breakthrough infections in vaccinated individuals: Measurement, causes and impact. Nature Reviews Immunology, 1–9. https://doi.org/10.1038/s41577-021-00662-4

Gollub, R. L. (2022). Brain changes after COVID revealed by imaging. Nature. https://doi.org/10.1038/d41586-022-00503-x

TikToks can easily go viral across the world, because video and music can be interpreted regardless of language.

Holden is praised for his comments while his seatmate is vilified. It doesn't seem right, should it be the other way around?

Trevor Bedford on Twitter. (n.d.). Twitter. Retrieved 1 April 2022, from https://twitter.com/trvrb/status/1447566558973231104

Getting a Vaccine. (n.d.). Retrieved 31 March 2022, from http://www.bccdc.ca/health-info/diseases-conditions/covid-19/covid-19-vaccine/getting-a-vaccine#under12

Mia Malan. (2021, November 25). [Thread] What is the potential impact of the new B.1.1.529 #COVID19 variant? @rjlessells: 1. It’s relatively simple to detect some B.1.1.529 cases, as it’s possible to use PCR tests to do this in some cases 2. B.1.1.529 = has many mutations across different parts of the virus https://t.co/ytktqLzJUi [Tweet]. @miamalan. https://twitter.com/miamalan/status/1463846528578109444

Shematologist, MD. (2021, August 7). Listen to @Schwarzenegger https://t.co/CpYJ5wwjFc [Tweet]. @acweyand. https://twitter.com/acweyand/status/1424080234241040387

Altmann, D. M., & Boyton, R. J. (2022). COVID-19 vaccination: The road ahead. Science, 375(6585), 1127–1132. https://doi.org/10.1126/science.abn1755

ReconfigBehSci. (2022, March 12). @rwjdingwall @mugecevik @RobFreudenthal it makes little sense to numerically compare this pandemic with all of the intervention that occurred directly with past ones where medicine and epidemiology where of a completely different standard to conclude that this one ‘wasn’t bad’. 1/2 [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1502681086819721223

Tseng, H. F., Ackerson, B. K., Luo, Y., Sy, L. S., Talarico, C. A., Tian, Y., Bruxvoort, K. J., Tubert, J. E., Florea, A., Ku, J. H., Lee, G. S., Choi, S. K., Takhar, H. S., Aragones, M., & Qian, L. (2022). Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants. Nature Medicine, 1–1. https://doi.org/10.1038/s41591-022-01753-y

Dr Ellie Murray, ScD 🇨🇦. (2022, February 18). If you have a little one who’s getting a vaccine soon but feeling a bit scared, this new book from @JanZauzmer is quite cute & might help them preview the experience. #VaccinesSaveLives https://t.co/MRngUYWsOJ [Tweet]. @EpiEllie. https://twitter.com/EpiEllie/status/1494695602248200198

Living with COVID-19: How the virus could turn into the common cold, or something far worse. (2022, January 9). The Mercury News. https://www.mercurynews.com/2022/01/09/living-with-covid-19-how-the-virus-could-turn-into-the-common-cold-or-something-far-worse

Benjamin Meyer. (2022, January 14). Here is a bit of a longer explanatory thread on our recent paper on “Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron”. You can read the full paper here: Https://t.co/R2FSyck6Nn [Tweet]. @BenjaminMeyer85. https://twitter.com/BenjaminMeyer85/status/1482102496764039176

Academics: Viral Evolution Scenarios, 10 February 2022. (n.d.). GOV.UK. Retrieved February 14, 2022, from https://www.gov.uk/government/publications/academics-viral-evolution-scenarios-10-february-2022

Niegowska, M., Wajda-Cuszlag, M., Stępień-Ptak, G., Trojanek, J., Michałkiewicz, J., Szalecki, M., & Sechi, L. A. (2019). Anti-HERV-WEnv antibodies are correlated with seroreactivity against Mycobacterium avium subsp. Paratuberculosis in children and youths at T1D risk. Scientific Reports, 9(1), 6282. https://doi.org/10.1038/s41598-019-42788-5

Camero, K. (n.d.). If You Think You Have COVID But Your Rapid Test Is Negative, Here’s Why. BuzzFeed News. Retrieved February 4, 2022, from https://www.buzzfeednews.com/article/katiecamero/negative-covid-test

Paolucci, S., Cassaniti, I., Novazzi, F., Fiorina, L., Piralla, A., Comolli, G., Bruno, R., Maserati, R., Gulminetti, R., Novati, S., Mojoli, F., Baldanti, F., Bruno, R., Mondelli, M., Brunetti, E., Matteo, A. D., Seminari, E., Maiocchi, L., Zuccaro, V., … Ferrari, A. (2021). EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. International Journal of Infectious Diseases, 104, 315–319. https://doi.org/10.1016/j.ijid.2020.12.051

Kozlov, M. (2022). How does Omicron spread so fast? A high viral load isn’t the answer. Nature. https://doi.org/10.1038/d41586-022-00129-z

Nast, C. (2022, January 15). Do the Omicron Numbers Mean What We Think They Mean? The New Yorker. https://www.newyorker.com/magazine/2022/01/24/do-the-omicron-numbers-mean-what-we-think-they-mean

Covid’s evolution: ‘With each passing wave, we’ve seen greater transmissibility.’ (n.d.). MSN. Retrieved January 15, 2022, from https://www.msn.com/en-us/news/us/covid-s-evolution-with-each-passing-wave-we-ve-seen-greater-transmissibility/vi-AARYwCn

Geddes, L., & correspondent, L. G. S. (2022, January 11). Will Covid-19 become less dangerous as it evolves? The Guardian. https://www.theguardian.com/world/2022/jan/11/will-covid-19-become-less-dangerous-as-it-evolves

Zaidi, A. K., & Dehgani-Mobaraki, P. (2021). RETRACTED ARTICLE: The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article. The Journal of Antibiotics, 1–1. https://doi.org/10.1038/s41429-021-00430-5

Yonker, L. M., Boucau, J., Regan, J., Choudhary, M. C., Burns, M. D., Young, N., Farkas, E. J., Davis, J. P., Moschovis, P. P., Bernard Kinane, T., Fasano, A., Neilan, A. M., Li, J. Z., & Barczak, A. K. (2021). Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children. The Journal of Infectious Diseases, 224(11), 1821–1829. https://doi.org/10.1093/infdis/jiab509

Chertow, Daniel, Sydney Stein, Sabrina Ramelli, Alison Grazioli, Joon-Yong Chung, Manmeet Singh, Claude Kwe Yinda, et al. ‘SARS-CoV-2 Infection and Persistence throughout the Human Body and Brain’, 28 December 2021. https://doi.org/10.21203/rs.3.rs-1139035/v1.

Herman, J. (2021, December 22). More than a million of us are suffering with long Covid – yet still it’s not taken seriously. The Guardian. https://www.theguardian.com/commentisfree/2021/dec/22/long-covid-pandemic-support-funding

Ning, C., Wu, H., & Liu, Y. (2021). Deliberation in health-related headlines. PsyArXiv. https://doi.org/10.31234/osf.io/e5bn7

Lai, J., German, J., Hong, F., Tai, S.-H. S., McPhaul, K. M., Milton, D. K., & Group, for the U. of M. S. R. (2021). Comparison of Saliva and Mid-Turbinate Swabs for Detection of COVID-19 (p. 2021.12.01.21267147). https://doi.org/10.1101/2021.12.01.21267147

Wheatley, A. K., & Juno, J. A. (2021). COVID-19 vaccines in the age of the delta variant. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00688-5

Nature Portfolio on Twitter. (n.d.). Twitter. Retrieved 14 November 2021, from https://twitter.com/NaturePortfolio/status/1459144019016040452

Pouwels, K. B., Pritchard, E., Matthews, P. C., Stoesser, N., Eyre, D. W., Vihta, K.-D., House, T., Hay, J., Bell, J. I., Newton, J. N., Farrar, J., Crook, D., Cook, D., Rourke, E., Studley, R., Peto, T. E. A., Diamond, I., & Walker, A. S. (2021). Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. Nature Medicine, 1–9. https://doi.org/10.1038/s41591-021-01548-7

Singanayagam, A., Hakki, S., Dunning, J., Madon, K. J., Crone, M. A., Koycheva, A., Derqui-Fernandez, N., Barnett, J. L., Whitfield, M. G., Varro, R., Charlett, A., Kundu, R., Fenn, J., Cutajar, J., Quinn, V., Conibear, E., Barclay, W., Freemont, P. S., Taylor, G. P., … Lackenby, A. (2021). Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: A prospective, longitudinal, cohort study. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00648-4

Kennedy-Shaffer, L., Kahn, R., & Lipsitch, M. (2021). Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load. Epidemiology (Cambridge, Mass.), 32(6), 820–828. https://doi.org/10.1097/EDE.0000000000001415

Peeples, L. (2021). COVID reinfections likely within one or two years, models propose. Nature. https://doi.org/10.1038/d41586-021-02825-8

ICMR removes Ivermectin, HCQ from revised guidelines on Covid-19 treatment. (2021, September 24). Hindustan Times. https://www.hindustantimes.com/india-news/icmr-removes-ivermectin-hcq-from-revised-guidelines-on-covid-19-treatment-101632461755113.html

Ghinwa El Hayek on Twitter. (n.d.). Twitter. Retrieved 4 October 2021, from https://twitter.com/GhinwaHayek/status/1411393046017630212

Gregory, A., & Weale, S. (2021, September 28). Covid: 37% of people have symptoms six months after infection. The Guardian. https://www.theguardian.com/world/2021/sep/28/covid-37-of-people-have-symptoms-six-months-after-infection

Eyre, D. W., Taylor, D., Purver, M., Chapman, D., Fowler, T., Pouwels, K., Walker, A. S., & Peto, T. E. (2021). The impact of SARS-CoV-2 vaccination on Alpha and Delta variant transmission (p. 2021.09.28.21264260). https://doi.org/10.1101/2021.09.28.21264260

Zimmer, C., Corum, J., & Wee, S.-L. (2020, June 10). Coronavirus Vaccine Tracker. The New York Times. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html

Israelow, B., Mao, T., Klein, J., Song, E., Menasche, B., Omer, S. B., & Iwasaki, A. (2021). Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2. Science Immunology. https://doi.org/10.1126/sciimmunol.abl4509

Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., Hernán, M. A., Lipsitch, M., Kohane, I., Netzer, D., Reis, B. Y., & Balicer, R. D. (2021). Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMoa2110475

Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re’em, Y., Redfield, S., Austin, J. P., & Akrami, A. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine, 0(0). https://doi.org/10.1016/j.eclinm.2021.101019

Al-Aly, Z., Xie, Y., & Bowe, B. (2021). High-dimensional characterization of post-acute sequelae of COVID-19. Nature, 594(7862), 259–264. https://doi.org/10.1038/s41586-021-03553-9

Lee Kennedy-Shaffer. (2021, May 6). .@rebeccajk13 and @mlipsitch showed how to use that to estimate efficacy against prevalent infection (https://t.co/LeXxqcumGS). [Tweet]. @LeeKShaffer. https://twitter.com/LeeKShaffer/status/1390322501817880581

Reardon, S. (2021). How the Delta variant achieves its ultrafast spread. Nature. https://doi.org/10.1038/d41586-021-01986-w

Lipsitch, M., & Kahn, R. (2021). Interpreting vaccine efficacy trial results for infection and transmission. Vaccine, 39(30), 4082–4088. https://doi.org/10.1016/j.vaccine.2021.06.011

Study finds potentially druggable process of SARS-CoV-2 replication. (n.d.). Retrieved June 24, 2021, from https://phys.org/news/2021-06-potentially-druggable-sars-cov-replication.html

More transmissible variant makes vaccinations more crucial, experts say. (2021, June 10). STAT. https://www.statnews.com/2021/06/10/more-transmissible-variant-covid-19-vaccinations-even-more-crucial/

Feng, L., Zhang, T., Wang, Q., Xie, Y., Peng, Z., Zheng, J., Qin, Y., Zhang, M., Lai, S., Wang, D., Feng, Z., Li, Z., & Gao, G. F. (2021). Impact of COVID-19 outbreaks and interventions on influenza in China and the United States. Nature Communications, 12(1), 3249. https://doi.org/10.1038/s41467-021-23440-1

García-Fiñana, M., & Buchan, I. E. (2021). Rapid antigen testing in COVID-19 responses. Science, 372(6542), 571–572. https://doi.org/10.1126/science.abi6680

Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00262-0

Israelow, B., Mao, T., Klein, J., Song, E., Menasche, B., Omer, S. B., & Iwasaki, A. (2021). Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2. BioRxiv, 2021.05.19.444825. https://doi.org/10.1101/2021.05.19.444825

Kennedy-Shaffer, L., Kahn, R., & Lipsitch, M. (2021). Estimating vaccine efficacy against transmission via effect on viral load [Preprint]. Infectious Diseases (except HIV/AIDS). https://doi.org/10.1101/2021.05.03.21256556

Kissler, S., Fauver, J. R., Mack, C., Tai, C. G., Breban, M. I., Watkins, A. E., Samant, R. M., Anderson, D. J., Ho, D. D., Grubaugh, N. D., & Grad, Y. (2021). Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2. https://dash.harvard.edu/handle/1/37366884

Diseases, T. L. I. (2021). An exceptional vaccination policy in exceptional circumstances. The Lancet Infectious Diseases, 21(2), 149. https://doi.org/10.1016/S1473-3099(21)00008-6

Parker-Pope, T. (2021, April 22). Do We Still Need to Keep Wearing Masks Outdoors? The New York Times. https://www.nytimes.com/2021/04/22/well/live/covid-masks-outdoors.html?smid=tw-share

Betsch, Cornelia, and Philipp Sprengholz. ‘The Human Factor between Airborne Pollen Concentrations and COVID-19 Disease Dynamics’. PsyArXiv, 16 April 2021. https://doi.org/10.31234/osf.io/hw9gf.

Covid Data Science. (2021) ‘UK Variant B.1.1.7 becoming the dominant strain in the USA - what does it mean for Spring/Summer?’. Accessed 26 March 2021. https://www.covid-datascience.com/post/uk-variant-b-1-1-7-becoming-the-dominant-strain-in-the-usa-what-does-it-mean-for-spring-summer

A Marm Kilpatrick. (2021, February 9). Vaccine efficacy in blocking infection & transmission (I think) We can now estimate the (minimum) reduction in transmission from the Moderna vaccine. Thread tl;dr Moderna vaccine blocks >90% (87-93%) of infections & 91% (89-94%) of transmission. *Critiques welcome! Https://t.co/GjQIo3v4oe [Tweet]. @DiseaseEcology. https://twitter.com/DiseaseEcology/status/1359213735424872450

Pariente, Nonia, and on behalf of the PLOS Biology Staff Editors. ‘We Need Leaders That Believe in Scientific Evidence’. PLOS Biology 18, no. 10 (22 October 2020): e3000992. https://doi.org/10.1371/journal.pbio.3000992.

Levine-Tiefenbrun, M., Yelin, I., Uriel, H., Kuint, J., Schreiber, L., Herzel, E., Katz, R., Ben-Tov, A., Patalon, T., Chodick, G., & Kishony, R. (2020). Association of COVID-19 RT-qPCR test false-negative rate with patient age, sex and time since diagnosis. MedRxiv, 2020.10.30.20222935. https://doi.org/10.1101/2020.10.30.20222935

„Up to 100 UK Children a Week Hospitalised with Rare Post-Covid Disease“. URL: http://www.theguardian.com/world/2021/feb/05/up-to-100-uk-children-a-week-hospitalised-with-rare-post-covid-disease

Talk radio has had this formula for years and they've almost had to use it to drive any listenership as people left radio for television and other media.

I can still remember the different "loudness" level of talk between Bill O'Reilly's primetime show on Fox News and the louder level on his radio show.

Bosco-Lauth, A. M., Hartwig, A. E., Porter, S. M., Gordy, P. W., Nehring, M., Byas, A. D., VandeWoude, S., Ragan, I. K., Maison, R. M., & Bowen, R. A. (2020). Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2013102117

Mondelli, Mario U., Marta Colaneri, Elena M. Seminari, Fausto Baldanti, and Raffaele Bruno. ‘Low Risk of SARS-CoV-2 Transmission by Fomites in Real-Life Conditions’. The Lancet Infectious Diseases 0, no. 0 (29 September 2020). https://doi.org/10.1016/S1473-3099(20)30678-2.

Franco-Paredes, Carlos, Nazgol Ghandnoosh, Hassan Latif, Martin Krsak, Andres F. Henao-Martinez, Megan Robins, Lilian Vargas Barahona, and Eric M. Poeschla. ‘Decarceration and Community Re-Entry in the COVID-19 Era’. The Lancet Infectious Diseases 0, no. 0 (29 September 2020). https://doi.org/10.1016/S1473-3099(20)30730-1.

Kaplan, Edward H, Dennis Wang, Mike Wang, Amyn A Malik, Alessandro Zulli, and Jordan H Peccia. ‘Aligning SARS-CoV-2 Indicators via an Epidemic Model: Application to Hospital Admissions and RNA Detection in Sewage Sludge’. Preprint. Infectious Diseases (except HIV/AIDS), 29 June 2020. https://doi.org/10.1101/2020.06.27.20141739.

Mike Caulfield on Twitter. (n.d.). Twitter. Retrieved September 23, 2020, from https://twitter.com/holden/status/1308205813475897344

Diseases, T. L. I. (2020). Curing COVID-19. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30706-4

Yelin, D., Wirtheim, E., Vetter, P., Kalil, A. C., Bruchfeld, J., Runold, M., Guaraldi, G., Mussini, C., Gudiol, C., Pujol, M., Bandera, A., Scudeller, L., Paul, M., Kaiser, L., & Leibovici, L. (2020). Long-term consequences of COVID-19: Research needs. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30701-5

Virus transmission from urinals. (2020). Physics of Fluids, 32(8), 081703. https://doi.org/10.1063/5.0021450